Most studies concentrated on the membranous PD-L1 expression of viable tumor cells, while emerging data suggest a potential role of PD-L1 expression on circulating or tumor infiltrating immune cells such as macrophages or lymphocytes [27, 28]. This evidence concerns the gene CD274 and neoplasm.